Diamedica Therapeutics Stock Price Transform Average Price

DMAC Stock  USD 8.04  0.43  5.08%   
DiaMedica Therapeutics price transform tool provides the execution environment for running the Average Price transformation and other technical functions against DiaMedica Therapeutics. DiaMedica Therapeutics value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of price transform indicators. As with most other technical indicators, the Average Price transformation function is designed to identify and follow existing trends. DiaMedica Therapeutics price transformation methods enable investors to generate trading signals using basic price transformation functions such as typical price movement.

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. DiaMedica Therapeutics Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.

DiaMedica Therapeutics Technical Analysis Modules

Most technical analysis of DiaMedica Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for DiaMedica from various momentum indicators to cycle indicators. When you analyze DiaMedica charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About DiaMedica Therapeutics Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of DiaMedica Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of DiaMedica Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing DiaMedica Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build DiaMedica Therapeutics's daily price indicators and compare them against related drivers, such as price transform and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of DiaMedica Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for DiaMedica Therapeutics, we also check how macroeconomic factors affect DiaMedica Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2025 2026 (projected)
Payables Turnover0.0070180.006202
Days Of Inventory On Hand0.09140.08
Hype
Prediction
LowEstimatedHigh
3.318.0512.79
Details
Intrinsic
Valuation
LowRealHigh
4.959.6914.43
Details
Naive
Forecast
LowNextHigh
2.907.6412.37
Details
4 Analysts
Consensus
LowTargetHigh
14.1115.5017.21
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as DiaMedica Therapeutics. Your research has to be compared to or analyzed against DiaMedica Therapeutics' peers to derive any actionable benefits. When done correctly, DiaMedica Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in DiaMedica Therapeutics.

Be your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Generate Optimal Portfolios

Align your risk and return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether DiaMedica Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DiaMedica Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Diamedica Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Diamedica Therapeutics Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DiaMedica Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For information on how to trade DiaMedica Stock refer to our How to Trade DiaMedica Stock guide.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Will Biotechnology sector continue expanding? Could DiaMedica diversify its offerings? Factors like these will boost the valuation of DiaMedica Therapeutics. Projected growth potential of DiaMedica fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every DiaMedica Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.71)
Return On Assets
(0.38)
Return On Equity
(0.64)
The market value of DiaMedica Therapeutics is measured differently than its book value, which is the value of DiaMedica that is recorded on the company's balance sheet. Investors also form their own opinion of DiaMedica Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is DiaMedica Therapeutics' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because DiaMedica Therapeutics' market value can be influenced by many factors that don't directly affect DiaMedica Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between DiaMedica Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding DiaMedica Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, DiaMedica Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.